Suppr超能文献

肿瘤抑制蛋白 HBP1 是一种新型的 c-myc 结合蛋白,可负调控 c-myc 转录活性。

The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.

机构信息

Department of Medical and Molecular Genetics, Oregon Health and Science University, Portland, Oregon 97239, USA.

出版信息

J Biol Chem. 2010 Feb 12;285(7):4847-58. doi: 10.1074/jbc.M109.074856. Epub 2009 Dec 11.

Abstract

c-Myc is an important transcription factor that regulates cellular proliferation, cell growth, and differentiation. A number of transcriptional co-factors for c-Myc have been described that have binding sites within highly conserved regions of the c-Myc transactivational domain (TAD). Given the importance of the c-Myc TAD, we set out to identify new proteins that interact with this region using a yeast two-hybrid assay. HBP1 was identified in our screen as a protein that interacts with full-length c-Myc but not a c-Myc mutant lacking the TAD. HBP1 is a transcriptional repressor and has been shown to negatively regulate the cell cycle. A correlation between HBP1 under-expression and breast cancer relapse has been described, suggesting that HBP1 may be an important tumor suppressor protein. We have found that HBP1 binds c-Myc in cells, and expression of HBP1 inhibits c-Myc transactivational activity at least partly by preventing c-Myc binding to target gene promoters. c-Myc binds to the C terminus of HBP1, a region lost in some breast tumors, and some HBP1 mutants found in breast cancer weakly interact with and/or no longer negatively regulate c-Myc. This work adds to our understanding of c-Myc regulation and mechanisms of tumor suppression by HBP1.

摘要

c-Myc 是一种重要的转录因子,可调节细胞增殖、细胞生长和分化。已经描述了许多 c-Myc 的转录共因子,它们在 c-Myc 反式激活结构域(TAD)的高度保守区域内具有结合位点。鉴于 c-Myc TAD 的重要性,我们着手使用酵母双杂交测定法鉴定与该区域相互作用的新蛋白质。在我们的筛选中,HBP1 被鉴定为与全长 c-Myc 相互作用但不与缺乏 TAD 的 c-Myc 突变体相互作用的蛋白质。HBP1 是一种转录抑制剂,已被证明可负调控细胞周期。已经描述了 HBP1 低表达与乳腺癌复发之间的相关性,这表明 HBP1 可能是一种重要的肿瘤抑制蛋白。我们发现 HBP1 在细胞中与 c-Myc 结合,并且 HBP1 的表达通过阻止 c-Myc 与靶基因启动子结合至少部分抑制 c-Myc 的反式激活活性。c-Myc 结合到 HBP1 的 C 末端,一些乳腺癌中丢失了这一区域,一些在乳腺癌中发现的 HBP1 突变体与 c-Myc 的相互作用较弱,或者不再对 c-Myc 起负调控作用。这项工作增加了我们对 c-Myc 调控和 HBP1 肿瘤抑制机制的理解。

相似文献

引用本文的文献

6
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.靶向去分化脂肪肉瘤中的MDM2-p53信号通路。
Front Oncol. 2022 Nov 10;12:1006959. doi: 10.3389/fonc.2022.1006959. eCollection 2022.
8
Targeting MYCN and ALK in resistant and relapsing neuroblastoma.靶向耐药和复发性神经母细胞瘤中的MYCN和ALK
Cancer Drug Resist. 2019 Sep 19;2(3):803-812. doi: 10.20517/cdr.2019.009. eCollection 2019.

本文引用的文献

2
Inhibition of c-Myc activity by ribosomal protein L11.核糖体蛋白L11对c-Myc活性的抑制作用。
EMBO J. 2007 Jul 25;26(14):3332-45. doi: 10.1038/sj.emboj.7601776. Epub 2007 Jun 28.
3
The many ways of Wnt in cancer.Wnt在癌症中的多种作用方式。
Curr Opin Genet Dev. 2007 Feb;17(1):45-51. doi: 10.1016/j.gde.2006.12.007.
6
The c-Myc target gene network.c-Myc靶基因网络。
Semin Cancer Biol. 2006 Aug;16(4):253-64. doi: 10.1016/j.semcancer.2006.07.014. Epub 2006 Jul 25.
9
The Pole3 bidirectional unit is regulated by MYC and E2Fs.
Gene. 2006 Jan 17;366(1):109-16. doi: 10.1016/j.gene.2005.07.046. Epub 2006 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验